Form 4 for CNMD CONMED Corp
Accepted 2021-10-05 00:00:00 ET · period of report 2021-10-04 · accession 0001127602-21-026746 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-05 | 2021-10-04 | CNMD | Garner Todd W | EVP, CFO | M - OptEx | $50.61 | +8,400 | 8,400 | New | +$425.1K |
| DM | 2021-10-05 | 2021-10-04 | CNMD | Garner Todd W | EVP, CFO | S - Sale+OE | $130.42 | -8,591 | 5,283 | -62% | -$1.12M |
| D | 2021-10-05 | 2021-10-04 | CNMD | Garner Todd W | EVP, CFO | M - OptEx | $0.00 | -8,400 | 39.6K | -18% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-04 | M | A | 8,400 | $50.61 | 8,400 | D | — | — | |
| 2 | Common | Common Stock | 2021-10-04 | S | D | 3,083 | $130.05 | 2,200 | D | — | — | (F7) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.72 to $130.60. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 3 | Common | Common Stock | 2021-10-04 | S | D | 800 | $131.49 | 1,400 | D | — | — | (F8) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.92 to $131.91. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 4 | Common | Common Stock | 2021-10-04 | S | D | 900 | $132.65 | 500 | D | — | — | (F9) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.11 to $133.10. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 5 | Common | Common Stock | 2021-10-04 | S | D | 500 | $133.45 | 0 | D | — | — | (F10) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.13 to $133.99. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 6 | Common | Common Stock | 2021-10-04 | S | D | 32 | $132.99 | 0 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.79 to $133.15. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 7 | Common | Common Stock | 2021-10-04 | S | D | 20 | $131.63 | 32 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.34 to $131.91. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 8 | Common | Common Stock | 2021-10-04 | S | D | 81 | $130.13 | 52 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.75 to $130.72. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 9 | Common | Common Stock | 2021-10-04 | S | D | 58 | $129.33 | 133 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.75 to $129.73. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 10 | Common | Common Stock | 2021-10-04 | S | D | 3,117 | $129.38 | 5,283 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.72 to $129.69. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 11 | Derivative | Options To Purchase Common Stock | 2021-10-04 | M | D | 8,400 | $0.00 | 39,600 | D | $50.61 · — to 2028-01-02 | 8,400 Common Stock | (F11) Each Stock Option represents a contingent right to receive one share of common stock, par value $0.001, per share of Conmed Corporation (the "Company") and was granted outside of the Company's existing equity plan as "employment inducement grants" under NASDAQ Listing Rule 5635(c)(4) and vest in equal amounts (20%) over a five year period on the January 2 anniversary date of the award, as further described in the Current Report filed with the SEC by the Company on January 2, 2018. |